ABVC Valuation

ABVC Biopharma Inc

Add to Watchlist

Advanced Chart

3.010

-0.51(-14.489%)1D

Overview
Forecast
Valuation
Earnings

ABVC Relative Valuation

ABVC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, ABVC is overvalued; if below, it's undervalued.

Historical Valuation

ABVC Biopharma Inc (ABVC) is now in the Fair zone, suggesting that its current forward PS ratio of 13.05 is considered Fairly compared with the five-year average of -6.05. The fair price of ABVC Biopharma Inc (ABVC) is between to according to relative valuation methord.

Relative Value

Fair Zone

Current Price：3.01

Fair

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

9.08

P/B

Median3y

1.43

Median5y

-1.47

-2.56

FCF Yield

Median3y

-37.04

Median5y

-25.65

Competitors Valuation Multiple

The average P/S ratio for ABVC's competitors is 35.89, providing a benchmark for relative valuation. ABVC Biopharma Inc Corp (ABVC) exhibits a P/S ratio of 13.05, which is -63.65% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap